Newsworthy

Crohn’s Disease Clinical Trial Recruitment

The AFFIRM Study is looking for adults who are 18 years of age or older, with moderate to severe Crohn’s disease (CD). The study is researching a study drug to see if it can safely be given subcutaneously (an injection under the skin) with the goal of inducing “remission” in adults with CD. Remission is the point where CD symptoms start to go away or disappear completely. To see whether you might be eligible, please visit our website www.AFFIRMstudyCD.com, or contact the Cotton O’Neil Digestive Health Clinical Research Center to learn more: (785) 270-4856.

Posted in

In Other News

Stormont Vail Health Provides Vaginal Births After Cesarean (VBAC)

2025 VBAC Promo-stormConn

Stormont Vail Health Provides Vaginal Births After Cesarean (VBAC)

07.19.23 - Breastfeeding Clinic Photos_124

Stormont Vail Health to Hold Annual Celebration of Life

2025 Celebration of Life Digital Graphics4 WeTogether StormConn

We Celebrate Kristi & Matt: May 2025 Persons of the Moment

2025_May_POM-Skinner-SM-1200x628

Patient, Team Member, Inspiration: Alofa’s Bariatric Surgery Story

2025.6.6 Alofa-Mariner-StormConn